Invention Grant
- Patent Title: Combination treatment for acute myeloid leukemia (AML)
-
Application No.: US14560086Application Date: 2014-12-04
-
Publication No.: US09956243B2Publication Date: 2018-05-01
- Inventor: Brian Higgins , Gwen Nichols , Kathryn E. Packman
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Nutley
- Assignee: HOFFMANN-LA ROCHE INC.
- Current Assignee: HOFFMANN-LA ROCHE INC.
- Current Assignee Address: US NJ Nutley
- Main IPC: A01N43/04
- IPC: A01N43/04 ; A61K31/70 ; A61K31/7068 ; A61K9/00 ; A61K31/40 ; A61K45/06 ; A61K31/77
Abstract:
The present invention relates to a pharmaceutical product comprising a) as a first component an inhibitor of the MDM2-p53 interaction such as, for example: and b) as a second component cytarabine; as a combined preparation for the sequential or simultaneous use in the treatment of cancer.
Public/Granted literature
- US20150157603A1 NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML) Public/Granted day:2015-06-11
Information query
IPC分类:
